Just diagnosed with New-onset refractory status epilepticus?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees New-onset refractory status epilepticus, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive New-onset refractory status epilepticus hub →Overview
New-onset refractory status epilepticus is a rare condition. Also known as NORSE. Tomeko brings together the specialists, research, clinical trials, treatments and community for New-onset refractory status epilepticus so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:363558 · ICD-10 G41.8 · GARD 0012244
Find care for New-onset refractory status epilepticus
Authoritative references for New-onset refractory status epilepticus
Research & market landscape for New-onset refractory status epilepticus
Following New-onset refractory status epilepticus for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for New-onset refractory status epilepticus — the real-world landscape behind the condition, in one place.
- Latest New-onset refractory status epilepticus research on PubMed ↗
- Recruiting New-onset refractory status epilepticus trials on ClinicalTrials.gov ↗
- Explore the New-onset refractory status epilepticus research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for New-onset refractory status epilepticus and every rare condition. See how Tomeko works with industry →
Common questions
What is New-onset refractory status epilepticus?
New-onset refractory status epilepticus is a rare condition. Also known as NORSE. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for New-onset refractory status epilepticus together in one place.
What are the symptoms of New-onset refractory status epilepticus?
Symptoms of New-onset refractory status epilepticus vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats New-onset refractory status epilepticus.
How is New-onset refractory status epilepticus treated?
Treatment for New-onset refractory status epilepticus depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see New-onset refractory status epilepticus, and review current options with them.
What causes New-onset refractory status epilepticus — is it genetic?
The cause and inheritance of New-onset refractory status epilepticus are described in the authoritative references linked on this page. A genetics or specialist clinician who treats New-onset refractory status epilepticus can explain what it means for you and your family.
I was just diagnosed with New-onset refractory status epilepticus — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees New-onset refractory status epilepticus, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for New-onset refractory status epilepticus?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat New-onset refractory status epilepticus, filtered to your area.
Are there clinical trials for New-onset refractory status epilepticus?
Tomeko shows live, recruiting studies for New-onset refractory status epilepticus from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- Acetazolamide-responsive myotonia
- Acquired porencephaly
- Actin accumulation myopathy
- Action myoclonus-renal failure syndrome
- Acute disseminated encephalomyelitis
- Acute disseminated encephalomyelitis with anti-MOG antibodies
- Acute disseminated encephalomyelitis without anti-MOG antibodies
- Acute encephalopathy with biphasic seizures and late reduced diffusion